Keyphrases
Synthetic Antibodies
100%
Viral Glycoprotein
100%
Membrane Proximal External Region
80%
VH1-69
60%
Human Immunodeficiency Virus Type 1 (HIV-1)
50%
Synthetic Antibody Library
50%
Antibody Isolation
49%
Isolation Method
43%
Influenza
33%
Vaccine Development
33%
Viral Antigens
33%
Membrane Fusion
33%
Ebola Virus
33%
Fusion Intermediate
33%
Viral Targets
30%
Monoclonal Antibody
26%
Conformation-specific Antibody
20%
Epitope Conformation
20%
Specific Yield
20%
Oligonucleotides
16%
Virus
16%
Specific Antibodies
16%
Interaction Mode
16%
Viral Membrane Fusion
16%
Broadly Neutralizing Antibodies
16%
High-affinity Antibodies
16%
Epitope
16%
Antibody Technology
16%
Antibody Engineering
16%
Phage Display Library
16%
Neutralization Activity
16%
Gp41
16%
Complementarity-determining Region 3 (CDR3)
16%
Membrane Virus
16%
Virus-neutralizing Antibody
16%
Germ Cells
16%
Immunotherapeutics
16%
Mechanistic Understanding
16%
Virus-specific
16%
Antibody Screening
16%
Viral Entry
16%
Envelope Glycoprotein
16%
Public Health
10%
Therapeutic Vaccine
10%
Technological Progress
10%
Therapeutic Agents
10%
Novel Antibodies
10%
Viral Infection
10%
Immunology and Microbiology
Viral Envelope
100%
Glycoprotein
100%
Synthetic Antibody
100%
Monospecific Antibody
57%
Antibody Isolation
33%
Human Immunodeficiency Virus 1
33%
Membrane Fusion
33%
Antibody Library
33%
Vaccine Efficacy
28%
Influenza
22%
Virus Antigen
22%
Conformation
22%
Epitope
22%
Ebola Virus
22%
Monoclonal Antibody
17%
Neutralizing Antibody
11%
Viral Entry
11%
Antibody Engineering
11%
Phage Display
11%
Neutralization
11%
Immunotherapy
11%
Complementarity Determining Region
11%
Gp41
11%
Virus Antibody
11%
Antibody Affinity
11%
Viral Disease
6%